Diagnostics and treatment of Clostridium difficile-associated disease: Guidelines of the Russian gastroenterological association

Aim of publication. To present with clinical guidelines of the Russian gastroenterological association on Clostridium difficile-associated disease management to practical doctors. Summary. Clostridium difficile-associated disease develops at disorders of intestinal microbiome with excessive coloniza...

Full description

Saved in:
Bibliographic Details
Main Authors: V. T. Ivashkin, N. D. Yushchuk, I. V. Mayev, Tatyana L Lapina, Ye. A. Poluektova, O. S. Shifrin, A. S. Tertychny, A. S. Trukhmanov, A. A. Sheptulin, Ye. K. Baranskaya, O. S. Lyashenko, K. V. Ivashkin
Format: Article
Language:Russian
Published: Gastro LLC 2018-08-01
Series:Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:
Online Access:https://www.gastro-j.ru/jour/article/view/84
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823860315516829696
author V. T. Ivashkin
N. D. Yushchuk
I. V. Mayev
Tatyana L Lapina
Ye. A. Poluektova
O. S. Shifrin
A. S. Tertychny
A. S. Trukhmanov
A. A. Sheptulin
Ye. K. Baranskaya
O. S. Lyashenko
K. V. Ivashkin
author_facet V. T. Ivashkin
N. D. Yushchuk
I. V. Mayev
Tatyana L Lapina
Ye. A. Poluektova
O. S. Shifrin
A. S. Tertychny
A. S. Trukhmanov
A. A. Sheptulin
Ye. K. Baranskaya
O. S. Lyashenko
K. V. Ivashkin
author_sort V. T. Ivashkin
collection DOAJ
description Aim of publication. To present with clinical guidelines of the Russian gastroenterological association on Clostridium difficile-associated disease management to practical doctors. Summary. Clostridium difficile-associated disease develops at disorders of intestinal microbiome with excessive colonization of C. difficile which toxins cause colonic inflammation and damage. C. difficile toxins A and B are major virulence factors causing damage of intestinal wall and inflammation due to damage of intestinal epithelial barrier, induction of proinflammatory cytokines, apoptosis and a necrosis of epithelial cells. Current epidemiologic trends of C. difficile-associated disease are characterized by growth of both inpatient and community-acquired morbidity, expansion of risk groups, increase in number of more severe cases including those, caused by more virulent BI/NAP1/027strain, tendency to relapsing, increase in lethal outcomes. C. difficile infection is the most common cause of intrahospital diarrhea leading to significant mortality. Risk factors of C. difficile-associated include antibacterial therapy, hospital admission, elderly age, comorbidity and immunosuppressive treatment. At the present time several laboratory methods for diagnosis of Clostridial infection exist: fecal ELISA test for toxins A and B, PCR, test for C. difficile glutamate dehydrogenase. Detection of densely adhered to underlying mucosa greenish or creamy deposits (pseudomembranes) is the endoscopical marker of severe C. difficile-associated disease i.e. pseudomembranous colitis. C. difficile-associated disease treatment includes vancomycin and metronidazole, the choice of drug and dose depends on disease severity. Significance of sorbents and probiotics in patient management is under discussion. Prophylaxis requires rational application of antibiotics, decrease, whenever possible, of terms of hospital stay, timely diagnosis and observance of sanitary and epidemiologic rules in medical institutions. Conclusion. Epidemiologic growth, risk of significant morbidity made C. difficile-associated disease a socially important disease. The present guidelines direct the doctor to correct diagnosis and adequate treatment of C. difficile infection.
format Article
id doaj-art-e6831bd74af34c6eac9b201825e95f69
institution Kabale University
issn 1382-4376
2658-6673
language Russian
publishDate 2018-08-01
publisher Gastro LLC
record_format Article
series Российский журнал гастроэнтерологии, гепатологии, колопроктологии
spelling doaj-art-e6831bd74af34c6eac9b201825e95f692025-02-10T16:14:28ZrusGastro LLCРоссийский журнал гастроэнтерологии, гепатологии, колопроктологии1382-43762658-66732018-08-01265566510.22416/1382-4376-2016-5-56-6584Diagnostics and treatment of Clostridium difficile-associated disease: Guidelines of the Russian gastroenterological associationV. T. Ivashkin0N. D. Yushchuk1I. V. Mayev2Tatyana L Lapina3Ye. A. Poluektova4O. S. Shifrin5A. S. Tertychny6A. S. Trukhmanov7A. A. Sheptulin8Ye. K. Baranskaya9O. S. Lyashenko10K. V. Ivashkin11Federal state educational government-financed institution of higher professional education «Sechenov First Moscow state medical university»State educational government-financed institution of higher professional education «Yevdokimov Moscow State University of Medicine and Dentistry»State educational government-financed institution of higher professional education «Yevdokimov Moscow State University of Medicine and Dentistry»Federal state educational government-financed institution of higher professional education «Sechenov First Moscow state medical university»Federal state educational government-financed institution of higher professional education «Sechenov First Moscow state medical university»Federal state educational government-financed institution of higher professional education «Sechenov First Moscow state medical university»Federal state educational government-financed institution of higher professional education «Sechenov First Moscow state medical university»Federal state educational government-financed institution of higher professional education «Sechenov First Moscow state medical university»Federal state educational government-financed institution of higher professional education «Sechenov First Moscow state medical university»Federal state educational government-financed institution of higher professional education «Sechenov First Moscow state medical university»Federal state educational government-financed institution of higher professional education «Sechenov First Moscow state medical university»Federal state educational government-financed institution of higher professional education «Sechenov First Moscow state medical university»Aim of publication. To present with clinical guidelines of the Russian gastroenterological association on Clostridium difficile-associated disease management to practical doctors. Summary. Clostridium difficile-associated disease develops at disorders of intestinal microbiome with excessive colonization of C. difficile which toxins cause colonic inflammation and damage. C. difficile toxins A and B are major virulence factors causing damage of intestinal wall and inflammation due to damage of intestinal epithelial barrier, induction of proinflammatory cytokines, apoptosis and a necrosis of epithelial cells. Current epidemiologic trends of C. difficile-associated disease are characterized by growth of both inpatient and community-acquired morbidity, expansion of risk groups, increase in number of more severe cases including those, caused by more virulent BI/NAP1/027strain, tendency to relapsing, increase in lethal outcomes. C. difficile infection is the most common cause of intrahospital diarrhea leading to significant mortality. Risk factors of C. difficile-associated include antibacterial therapy, hospital admission, elderly age, comorbidity and immunosuppressive treatment. At the present time several laboratory methods for diagnosis of Clostridial infection exist: fecal ELISA test for toxins A and B, PCR, test for C. difficile glutamate dehydrogenase. Detection of densely adhered to underlying mucosa greenish or creamy deposits (pseudomembranes) is the endoscopical marker of severe C. difficile-associated disease i.e. pseudomembranous colitis. C. difficile-associated disease treatment includes vancomycin and metronidazole, the choice of drug and dose depends on disease severity. Significance of sorbents and probiotics in patient management is under discussion. Prophylaxis requires rational application of antibiotics, decrease, whenever possible, of terms of hospital stay, timely diagnosis and observance of sanitary and epidemiologic rules in medical institutions. Conclusion. Epidemiologic growth, risk of significant morbidity made C. difficile-associated disease a socially important disease. The present guidelines direct the doctor to correct diagnosis and adequate treatment of C. difficile infection.https://www.gastro-j.ru/jour/article/view/84clostridium difficile-ассоци иро-ванная болезньэпидемиологияпатогенезклини-кадиагностикалечениепрофилактика
spellingShingle V. T. Ivashkin
N. D. Yushchuk
I. V. Mayev
Tatyana L Lapina
Ye. A. Poluektova
O. S. Shifrin
A. S. Tertychny
A. S. Trukhmanov
A. A. Sheptulin
Ye. K. Baranskaya
O. S. Lyashenko
K. V. Ivashkin
Diagnostics and treatment of Clostridium difficile-associated disease: Guidelines of the Russian gastroenterological association
Российский журнал гастроэнтерологии, гепатологии, колопроктологии
clostridium difficile-ассоци иро-ванная болезнь
эпидемиология
патогенез
клини-ка
диагностика
лечение
профилактика
title Diagnostics and treatment of Clostridium difficile-associated disease: Guidelines of the Russian gastroenterological association
title_full Diagnostics and treatment of Clostridium difficile-associated disease: Guidelines of the Russian gastroenterological association
title_fullStr Diagnostics and treatment of Clostridium difficile-associated disease: Guidelines of the Russian gastroenterological association
title_full_unstemmed Diagnostics and treatment of Clostridium difficile-associated disease: Guidelines of the Russian gastroenterological association
title_short Diagnostics and treatment of Clostridium difficile-associated disease: Guidelines of the Russian gastroenterological association
title_sort diagnostics and treatment of clostridium difficile associated disease guidelines of the russian gastroenterological association
topic clostridium difficile-ассоци иро-ванная болезнь
эпидемиология
патогенез
клини-ка
диагностика
лечение
профилактика
url https://www.gastro-j.ru/jour/article/view/84
work_keys_str_mv AT vtivashkin diagnosticsandtreatmentofclostridiumdifficileassociateddiseaseguidelinesoftherussiangastroenterologicalassociation
AT ndyushchuk diagnosticsandtreatmentofclostridiumdifficileassociateddiseaseguidelinesoftherussiangastroenterologicalassociation
AT ivmayev diagnosticsandtreatmentofclostridiumdifficileassociateddiseaseguidelinesoftherussiangastroenterologicalassociation
AT tatyanallapina diagnosticsandtreatmentofclostridiumdifficileassociateddiseaseguidelinesoftherussiangastroenterologicalassociation
AT yeapoluektova diagnosticsandtreatmentofclostridiumdifficileassociateddiseaseguidelinesoftherussiangastroenterologicalassociation
AT osshifrin diagnosticsandtreatmentofclostridiumdifficileassociateddiseaseguidelinesoftherussiangastroenterologicalassociation
AT astertychny diagnosticsandtreatmentofclostridiumdifficileassociateddiseaseguidelinesoftherussiangastroenterologicalassociation
AT astrukhmanov diagnosticsandtreatmentofclostridiumdifficileassociateddiseaseguidelinesoftherussiangastroenterologicalassociation
AT aasheptulin diagnosticsandtreatmentofclostridiumdifficileassociateddiseaseguidelinesoftherussiangastroenterologicalassociation
AT yekbaranskaya diagnosticsandtreatmentofclostridiumdifficileassociateddiseaseguidelinesoftherussiangastroenterologicalassociation
AT oslyashenko diagnosticsandtreatmentofclostridiumdifficileassociateddiseaseguidelinesoftherussiangastroenterologicalassociation
AT kvivashkin diagnosticsandtreatmentofclostridiumdifficileassociateddiseaseguidelinesoftherussiangastroenterologicalassociation